Issue 2 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

2

February 29, 2008Feb 29, 2008

Free

DOWNLOAD THE PDF

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

Smoking Increases Breast Cancer Risk Based on Genes

Larynx Preservation Provides Better Voice Quality For Patients

PET Better At Evaluating Response In Sarcoma

Sorafenib Targets AML Driven By Mutant FLT3 Gene

NCI Cooperative Group, Cancer Center Trials Listed

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025